‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy By: MarketWatch May 20, 2022 at 10:34 AM EDT Watch for these 3 catalysts and consider these 6 stocks. Read More >> Related Stocks: Bristol-Myers Squibb Fate Therapeutics Johnson & Johnson Lianbio ADR Moderna Inc Nasdaq Biotechnology Ishares ETF Novavax Inc Olema Pharmaceuticals Inc Pfizer S&P Biotech SPDR S&P Oil & Gas Expl & Prod SPDR Ucb ADR Ventyx Biosciences Inc Vertex Pharmaceuticals
